Prevention and management of ovarian hyperstimulation syndrome

Aboulghar, 2003, Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures, Hum Reprod Update, 9, 275, 10.1093/humupd/dmg018 Aboulghar M, Evers JH, Al-Inany H. Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome. Cochrane Database of Systematic Reviews 2, 2004. Chen, 2000, Value of serum and follicular fluid cytokine profile in the prediction of moderate to severe ovarian hyperstimulation syndrome, Hum Reprod, 15, 1037, 10.1093/humrep/15.5.1037 D’Angelo A, Amso N. Embryo freezing for preventing ovarian hyperstimulation syndrome. Cochrane Database of Systematic Reviews 2, 2004. D’Angelo A, Amso N. ‘Coasting’ (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome. Cochrane Database of Systematic Reviews 2, 2004. Evbuomvan, 2000, Coexistent haemoconcentration and hypoosmolality during superovulation and in severe ovarian hyperstimulation syndrome: a volume homeostasis paradox, Fertil Steril, 74, 67, 10.1016/S0015-0282(00)00573-2 Geva, 2000, Role of vascular endothelial growth factor in ovarian physiology and pathology, Fertil Steril, 74, 429, 10.1016/S0015-0282(00)00670-1 Kobayashi, 1998, The kallikrein–kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome, J Mol Endocrinol, 20, 363, 10.1677/jme.0.0200363 Mathur, 2000, Distinction between early and late ovarian hyperstimulation syndrome, Fertil Steril, 73, 901, 10.1016/S0015-0282(00)00492-1 2003, Ovarian hyperstimulation syndrome, Fertil Steril, 80, 1309, 10.1016/S0015-0282(03)02194-0